Complete Guide to Getting Takhzyro (lanadelumab-flyo) Approved by Cigna in Texas: Requirements, Appeals, and Timelines
Answer Box: Getting Takhzyro Approved by Cigna in Texas
Cigna requires prior authorization for Takhzyro (lanadelumab-flyo) with confirmed HAE type I/II diagnosis, low C1-INH levels (<50% normal), and low C4 levels. Submit through your HAE specialist with lab documentation, attack logs, and medical necessity letter via Cigna'